Novel plant triterpenoid drug amooranin overcomes multidrug resistance in human leukemia and colon carcinoma cell lines

International Journal of Cancer

Volumn 105, Issue 6, 2003, Pages 784-789

  Ramachandran, Cheppail ^a   Rabi, Thangaiyan ^a   Fonseca, Hugo B ^a   Melnick, Steven J ^a   Escalon, Enrique A ^a  

^a MIAMI CHILDREN'S HOSPITAL   (United States)

Author keywords

Amooranin; Cell cycle; Cytotoxicity; Multidrug resistance; Novel drug; p glyco protein

Indexed keywords

AMOORANIN; AZIDOPINE; CELL DNA; DOXORUBICIN; GLYCOPROTEIN P; TRITERPENOID; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RESISTANCE; COLON CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA CONTENT; DRUG ACCUMULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA; MULTIDRUG RESISTANCE; PHOTOAFFINITY LABELING; PHYTOCHEMISTRY; PRIORITY JOURNAL;

AFFINITY LABELS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AZIDES; CARCINOMA; CELL CYCLE; CELL SURVIVAL; COLONIC NEOPLASMS; DIHYDROPYRIDINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; LEUKEMIA; P-GLYCOPROTEIN; TRITERPENES; TUMOR CELLS, CULTURED;

EID: 0038457894     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11180     Document Type: Article

References (25)

1. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann Rev Biochem 1993;62:385-427.
2. Moscow JA, Cowan KH. Multidrug resistance. J Natl Cancer Inst 1988;80:14-20.
3. Biedler JL. Genetic aspects of multidrug resistance. Cancer 1992;70(Suppl):1799-809.
4. Ford JM. Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitizers. Eur J Cancer 1996;32A:991-1001.
5. Sikic BI. Pharmacological approaches to reversing multidrug resistance. Semin Oncol 1997;34:40-7.
6. Lum BL, Fisher G, Brophy NA, Yahanda AM, Kaubisch S, Halsy J, Sikic BI. Clinical trials of modulation of multidrug resistance: pharmacokinetic and pharmacodynamic considerations. Cancer 1993;72:3502-14.
7. Bates SF, Chen C, Robey R, Kang M, Figg WD, Fojo T. Reversal of multidrug resistance: lessons from clinical oncology. Novartis Found Symp 2002;243:83-102.
8. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 1989;41:1967-72.
9. Ford JM, Hait WN. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 1990;42:156-99.
10. Ford JM. Modulators of multidrug resistance: preclinical studies. Hematol Oncol Clin North Am 1995;9:337-55.
11. Prasad GC. Studies on cancer in Ayurveda and its management. J Res Ayurveda Sidda 1994;8:147-57.
12. Rabi T, Gupta RC, Gulati AK. Influence of Amoora rohituka on MCF-7 human mammary adenocarcinoma cells in vitro. Ind J Pharm Sci 1994;56:136-7.
13. Rabi T, Gupta RC. Antitumor and cytotoxic investigation of Amoora rohituka. Int J Pharmacogn 1995;33:359-61.
14. Rabi, T, Karunagaran D, Nair NK, Bhattathiri VN. 2001. Cytotoxic activity of amooranin and its derivatives. Phytother Res 2001;15:1-3.
15. Rabi T. Antitumor activity of amooranin from Amoora rohituka stem bark. Curr Sci 1996;70:80-1.
16. Rabi T, Ramachandran C, Melnick SJ, Fonseca HB, Escalon E, Jhabvala P. Amooranin overcomes cellular drug resistance and acts synergistically with doxorubicin in multidrug resistant human colon carcinoma and leukemia cell lines. Proceedings of the 2001 AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics - Discover, Biology and Clinical Applications, 2001. 88.
17. Ramachandran C, Mead D, Wellham LL, Sauerteig A, Krishan A. Expression of drug resistance-associated mdr-1, GST π and topoisomerase II genes during cell cycle traverse. Biochem Pharmacol 1995;49:545-52.
18. Ramachandran C. Kunikane H, You W, Krishan A. Phorbol esterinduced P-glycoprotein phosphorylation and functionality in the HTB-123 human breast cancer cell line. Biochem Pharmacol 1998;56:709-18.
19. Chen G, Ramachandran C, Krishan A. Thaliblastine, a plant alkaloid, circumvents multidrug resistance by direct binding to P-glycoprotein. Cancer Res 1993;53:2544-7.
20. Beck WT, Qian X. Photoaffinity substrates for P-glycoprotein. Biochem Pharmacol 1992;43:89-93.
21. Zamora JM, Pearce HL, Beck WT. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol Pharmacol 1998;33:454-62.
22. Pearce HL, Winter MA, Beck WT. Structural characteristics of compounds that modulate multidrug resistance. Adv Enzyme Regul 1990;30:357-73.
23. Rabi T, Ramachandran C, Fonseca HB, Alamo A, Melnick SJ, EscaIon E. Amooranin, a novel chemotherapeutic drug, induces apoptosis through caspase activity in human breast carcinoma cell lines. Breast Cancer Res Treat 2002 (in press).
24. Lehne G, De Angelis P, den Boer M, Rugstad HE. Growth inhibition, cytokinesis failure and apoptosis of multidrug-resistant leukemia cells after treatment with P-glycoprotein inhibitory agents. Leukemia 1999;13:768-78.
25. Ferlini C, Distefano M, Pignatelli F, Lin S, Lin S, Riva A, Bombardelli E, Mancusa S, Ojima I, Scambia G. Antitumor activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors. Br J Cancer 2000;83:1762-8.